U.S. Tech Hardware Stock News

Insulet (PODD) just put up third quarter FY 2025 numbers with revenue of US$706.3 million and basic EPS of US$1.24, alongside net income of US$87.6 million, setting the tone for how the rest of the year is shaping up. The company has seen revenue move from US$488.5 million in Q2 2024 to US$649.1 million in Q2 2025 and US$706.3 million in Q3 2025, while basic EPS shifted from US$2.69 to US$0.32 and then US$1.24 over the same quarters. This gives investors a clear view of how the top line and...

Caesars Entertainment (CZR) closed out FY 2025 with fourth quarter revenue of US$2.9 billion, a basic EPS loss of US$1.23 and a net income loss of US$250 million, compared with revenue of US$2.8 billion, basic EPS of US$0.05 and net income of US$11 million in the same quarter a year earlier. Over the past year, the company has seen quarterly revenue range from US$2.8 billion to US$2.9 billion, while basic EPS moved from a US$0.27 loss in Q3 2025 to a US$1.23 loss in Q4 2025. Trailing twelve...

Element Solutions (ESI) just wrapped up FY 2025 with fourth quarter revenue of US$676.2 million and basic EPS of US$0.03, alongside trailing twelve month revenue of US$2.6 billion and EPS of US$0.79 that sit against a net profit margin of 7.5%. Over recent quarters the company has seen revenue move from US$593.7 million and EPS of US$0.40 in Q1 2025 to US$676.2 million and EPS of US$0.03 in Q4 2025, while the last 12 months also include a US$59.0 million one off gain and a P/E of 42.9x that...

JBG SMITH Properties (JBGS) has capped FY 2025 with fourth quarter revenue of US$127.7 million, a basic EPS loss of US$0.75, and funds from operations of US$13.9 million in losses, setting a cautious tone around earnings quality. The company has seen quarterly revenue move from US$130.4 million in Q4 2024 to US$127.7 million in Q4 2025. Trailing twelve month revenue sits at US$498.6 million and EPS over the same period is a loss of US$2.06, which keeps the focus squarely on how efficiently...

USANA Health Sciences (USNA) closed FY 2025 with Q4 revenue of US$226.2 million and a basic EPS loss of US$0.10, as net income excluding extra items came in at a loss of US$1.8 million. Over the last six reported quarters, revenue has moved between US$200.2 million and US$249.5 million, while quarterly basic EPS has ranged from a profit of US$0.56 to a loss of US$0.36, and trailing twelve month EPS stood at US$0.58 on revenue of US$925.3 million in Q4 2025. For investors, the key story this...

MKS (MKSI) has wrapped up FY 2025 with Q4 revenue of US$1.0b and basic EPS of US$1.60, alongside trailing twelve month revenue of US$3.9b and EPS of US$4.38 that sit against a 55.3% earnings lift over the past year. The company has seen quarterly revenue move from US$934m in Q4 2024 to US$1.0b in Q4 2025, while basic EPS shifted from US$1.35 to US$1.60 over the same period. Analysts are forecasting 27.9% annual earnings growth and higher net profit margins, keeping investor attention firmly...

Mach Natural Resources (NYSE:MNR) is working through integration challenges tied to newly acquired oil assets in the Central Basin Platform. At the same time, the company has announced an increase in its quarterly cash distribution to unitholders. The combination of operational complexity and higher cash returns has drawn fresh attention from investors and analysts. Mach Natural Resources comes into this news with a recent unit price of $13.31 and a mixed return profile. The units are up...

If you are wondering whether AngloGold Ashanti at around US$106 per share still offers value after a strong run, this article will walk through what the current price might imply. The stock has had a mixed short term patch, with a 2.2% decline over the last 7 days, a 7.2% gain over 30 days, and returns of 24.0% year to date and 246.5% over the past year, while the 3 year return is very large and the 5 year return is more than 4x. Recent coverage has focused on AngloGold Ashanti's move to the...

NewAmsterdam Pharma has begun late stage RUBENS Phase 3 trials of obicetrapib in patients with Type 2 diabetes and metabolic syndrome. The company also plans to launch a new trial of obicetrapib in early Alzheimer's disease. These programs expand obicetrapib's potential use into major cardiometabolic and neurological conditions. For investors watching NasdaqGM:NAMS, these trial moves come as the stock trades at $35.24 and has returned 75.8% over the past year and 237.2% over the past five...

If you are trying to figure out whether Bitgo Holdings at around US$10.87 is a bargain or a value trap, starting with a clear view of what the current price reflects can help you frame the opportunity and the risks. The stock has seen a 1.4% decline over the last 7 days and a 41.2% decline year to date, which can change how the market views its growth potential and risk profile. Recent coverage around Bitgo Holdings has focused on its role in digital asset custody and broader crypto market...

Investors may be wondering whether Devon Energy at around US$44.04 is offering good value right now, or if most of the opportunity is already priced in. The stock has returned 1.3% over the last 7 days, 21.7% over the last 30 days, 16.3% year to date, 29.8% over 1 year, and 164.3% over 5 years, while the 3 year return sits at a 7.4% decline. This gives a mixed picture of how the market has treated the shares over time. Recent coverage has focused on Devon Energy's position in the US energy...

In February 2026, Black Hills Corporation reported past fourth-quarter 2025 results showing sales of US$635.5 million and net income of US$104.9 million, with diluted earnings per share from continuing operations of US$1.39. For the full year 2025, Black Hills grew sales to US$2.31 billion and net income to US$291.6 million, with diluted continuing EPS of US$3.98, highlighting consistent year-on-year earnings expansion. We’ll now consider how this earnings growth, particularly the full-year...

Why Canaan’s latest numbers matter for shareholders Canaan (NasdaqGM:CAN) just released fourth quarter and full year 2025 results, fresh earnings guidance for the first quarter of 2026, and January Bitcoin production data, giving investors several new reference points to assess the stock. For the fourth quarter ended December 31, 2025, Canaan reported revenue of US$196.27 million, compared with US$88.77 million a year earlier. The company recorded a net loss of US$85.04 million for the...

Charles River Laboratories International (NYSE:CRL) has appointed Glenn G. Coleman as Chief Financial Officer. The company has also named Kerry Dailey as Chief Legal Officer, expanding its senior leadership bench. These leadership changes are aimed at reinforcing financial oversight, legal governance, and corporate compliance. Charles River Laboratories operates as a key partner for pharmaceutical and biotech companies, supporting drug discovery, preclinical research, and related services...

The Brink’s Company has appointed Adrian Button as executive vice president and president of Brink’s North America, effective February 16, 2026, adding him to the executive leadership team reporting to CEO Mark Eubanks. With more than 30 years of global operational leadership at GE, NCR, and Carrier overseeing multibillion-dollar businesses and large-scale supply chains, Button’s background directly aligns with Brink’s focus on operational efficiency and service quality in North...

As February begins, major U.S. stock indexes have shown strong performance, with the Dow Jones Industrial Average climbing 515 points and the S&P 500 nearing a record high. Amid this positive momentum, investors may find opportunities in stocks that appear to be trading below their estimated fair value, potentially offering attractive entry points in a market characterized by robust gains and evolving economic conditions.

As February 2026 kicks off, major stock indexes in the United States have shown impressive gains, with the Dow Jones Industrial Average climbing by 515 points and the S&P 500 nearing a record high. In such a buoyant market atmosphere, investors often look beyond established giants to explore opportunities in lesser-known areas like penny stocks. Although 'penny stock' is an older term, it still denotes smaller or newer companies that can offer significant potential when backed by strong...

Otter Tail (OTTR) has just posted its FY 2025 numbers, with fourth quarter revenue of US$308.1 million and basic EPS of US$1.24, alongside trailing twelve month revenue of about US$1.3 billion and EPS of US$6.59 setting the backdrop. Over recent periods, revenue has ranged from US$303.1 million in Q4 2024 to US$337.4 million in Q1 2025, while quarterly EPS has moved between US$1.31 and US$2.04, giving investors a clear read on how margins are holding up against this revenue base. With a...

Insider lock up extension puts Regencell Bioscience Holdings (RGC) insider activity in focus Regencell Bioscience Holdings (RGC) has extended insider lock up commitments for directors and employees by one year, covering previously granted stock options and keeping insiders restricted from selling for a longer period. See our latest analysis for Regencell Bioscience Holdings. The lock up extension comes after a sharp shift in sentiment, with a 90 day share price return of 150.16% and year to...

If you are wondering whether eXp World Holdings at around US$7.50 is a bargain or a value trap, you are not alone, and this article is built to help you frame that question clearly. The share price is around US$7.50, with returns of 2.7% decline over 7 days, 21.4% decline over 30 days, 17.6% decline year to date, 32.3% decline over 1 year and 41.2% decline over 3 years. This raises fair questions about how the market currently views its prospects and risks. Recent news coverage has focused...

Gentex Corporation recently launched the Ops-Core Voice Projection Unit (VPU), an add-on to its Special Operations Tactical Respirator that enhances mission-critical voice clarity with three adjustable volume levels and integration into existing communication systems for tactical operators. This move extends Gentex’s communication suite beyond its core automotive and dimmable glass products, highlighting how defense-oriented innovation can broaden its end-market exposure. Next, we’ll examine...

Fluor (FLR) capped FY 2025 with Q4 revenue of US$4.2 billion and a basic EPS loss of US$9.77, alongside a net loss excluding extra items of US$1.6 billion that keeps profitability in focus for investors. The company has seen quarterly revenue move between US$3.4 billion and US$4.3 billion over the past six reported periods, while basic EPS has swung from a profit of US$14.91 in Q2 2025 to losses such as US$4.30 in Q3 2025, setting a volatile earnings backdrop for today’s release. With...

In February 2026, MasterBrand, Inc. reported fourth-quarter 2025 sales of US$644.6 million, a net loss of US$42 million, and a sharp drop in full-year net income to US$26.7 million despite slightly higher annual sales of US$2.73 billion. The company also projected a mid-to-high single-digit year-over-year decline in first-quarter 2026 net sales and disclosed that it had effectively paused share repurchases after buying back 226,914 shares earlier under its existing program. We will now...

Insiders who bought US$666.6k worth of Sportsman's Warehouse Holdings, Inc.'s ( NASDAQ:SPWH ) stock at an average buy...